Viewing Study NCT02541227


Ignite Creation Date: 2025-12-25 @ 5:11 AM
Ignite Modification Date: 2026-02-27 @ 3:14 AM
Study NCT ID: NCT02541227
Status: TERMINATED
Last Update Posted: 2022-04-06
First Post: 2015-08-28
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Cerebrolysin REGistry Study in Stroke
Sponsor: Ever Neuro Pharma GmbH
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: EVER-GB-0514
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None NETWORK View